The need for speed: how drug target discovery can drive change in precision medicine
Employee Perspective: Cyclica’s Marketing and Communications Specialist, Rebecca Woelfle
From molecule to medicine
Employee Spotlight - Rebecca Woelfle
Rebecca Woelfle is Cyclica’s Marketing Communications Specialist, where she is responsible for...
Demystifying Protein Structure Prediction Models: AlphaFold, RosettaFold, ESMFold and beyond
The purpose of this blog post is to provide an introduction to protein structure prediction models,...
The Complexity of Data in Machine Learning for Drug Discovery
Machine Learning (ML) pipelines are characterized by their multi-component iterative lifecycle,...
Recognizing Transformative Potential in the Protein Universe
Last August, I posted an article titled “The Protein Universe: Structural Biology Has Entered Its...
Response to Scripps Research Institute Paper on DCAF-1
A vast majority of protein targets in the human proteome have been deemed undruggable given the...
AI is not the Silver Bullet
As innovators, entrepreneurs, and operators, we have a responsibility to ensure that our...
Employee Spotlight - Holly McQuarrie
A small town girl that moved to the big city, who has had numerous jobs/careers; from a CNC...
Pitfalls in AI Drug Discovery
Artificial Intelligence (AI), or more modestly machine learning, is increasingly being used in many...
Artificial Intelligence in Drug Discovery
Artificial Intelligence (AI) systems, specifically machine learning (ML) technologies, learn how to...